chrisvoncsefalvay/vaers-outcomes huggingface dataset:
It has spread become very itchy; had a rash start up 7 days after my 2nd shotshot; Fever; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (It has spread become very itchy), RASH (had a rash start up 7 days after my 2nd shotshot), PYREXIA (Fever) and FATIGUE (fatigue) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRURITUS (It has spread become very itchy), RASH (had a rash start up 7 days after my 2nd shotshot), PYREXIA (Fever) and FATIGUE (fatigue). At the time of the report, PRURITUS (It has spread become very itchy), RASH (had a rash start up 7 days after my 2nd shotshot), PYREXIA (Fever) and FATIGUE (fatigue) outcome was unknown.            No concomitant medication was reported.  No treatment medication was reported.  For mRNA-1273 (COVID 19 Vaccine Moderna), the reporter did not provide any causality assessments.
persistent headaches, confusion, brain slowing(cant process info effectively) numbness and dizziness
little bit of a fever and tired; little bit of a fever and tired; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558).  A 75 year-old male patient received bnt162b2 (BNT162B2), administration date 04Feb2021 (Lot number: EM9810) at the age of 75 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PYREXIA (non-serious), FATIGUE (non-serious), outcome "unknown" and all described as "little bit of a fever and tired". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The patient received second dose of vaccine (LOT-Unknown, Second Dose 25Feb2021)  Dosages and Expiration Dates of vaccines unknown.  No follow-up attempts are possible. No further information is expected.          Follow-Up (13Oct2021): Follow-up attempts are completed. No further information is expected.
Hives and itching that started on the evening of 02/20/2020, did not report specific time. At school school nurse observed that child was very itchy and contacted the parent. PCP confirmed no respiratory distress and advised that child be evaluated in office. Child seen in office and noted to have  Hive right arm, backs of bilat legs and abdomen. Dose of ala-hist given in office and pt discharged.
Information received from subject's mother regarding 21 year old male received 1st dose Anthrax vaccine 6/7/01. Began noticing symptoms beginning around 10/01, including hair loss, nose bleeds at night, fatigue, and weight loss. The subject was sent overseas in October 2002 and was seen by a physician multiple times for symptoms including vomiting, excessive fatigue and possible sleep apnea. The subject returned home from vacation in May 2003. He received medical care for blood in his urine, back pain over the kidney area, feeling sick to his stomach, and stunned bowel. He was hospitalized and underwent surgery for gangrenous small intestine. The subject's kidneys stopped functioning properly, and he gained 55 pounds of fluid. On 6/1/03, the subject was sent to hospital and began dialysis 6/3/03. The subject was hospitalized for 4 months and discharged in September. He continued with dialysis for 9 months until 01/04. Currently he has a stent in one kidney, and both kidneys are functioning. The last creatinine was 3.2. By 6/13/03, the subject was diagnosed with Vasculitis Glomerulonephritis. He has since been diagnosed with Microscopic Polytonitis and Vasculitis Polynodosa. The subject has been seen by a urologist, rheumatologist, nephrologist, orthopedist in addition to his internist. He is now home and continues with medical care at least twice a week. Recently, he had a kidney infection. Current medications included: Prednisone, Lisinopril, Cellcept (on hold during kidney infection treatment), Toprol, Trotonix, Phoslo, Nephrovite, Folic Acid and Fosomax. Per annual follow up report: Son will always have glomerulonephritis for rest of his life. Also can not bend knees and has trouble with fingers and hands as well.
Acute pain of left shoulder; Dysfunction of left rotator cuff; Adverse effect of vaccine, subsequent encounter; LOC (loss of consciousness); We discussed that the loss of consciousness with urinary incontinence is likely related to the severe pain. She had a similar LOC with severe back pain. 03/27/2019: She was definitely fine" before the shingles vaccination. Looking back she states that chronology of events: shingles vaccination (was painful when administered); Then it was okay but started to hurt after about a few hours; She was in pain in the left shoulder and arm; "crackling sounds" with moving the arm; then it got worse: stabbing, aching and intense "and it did not let up." She felt she passed out due to the pain and she had urinated in the bed; she called 911, was seen in the, ER: All the time it was the left arm that was "hurting so bad" in the area of the shot and around the area up the shoulder areas; It was not red then. It was hard for her to move her left shoulder. She was in pain in the left shoulder and arm; "crackling sounds" with moving the arm; 03/27/2019: She was seen in the emergency department for left arm pain. She had a shingles vaccination that same day (earlier in the afternoon). Examination did not show skin or bone deformity of the left arm; CT scan of the head showed no stroke; lab did not show concerning results; red blood cell count was decreased with no overt bleeding; EKG did not show acute changes; thought to be related to shingles vaccination; lidocaine cream, acetaminophen, follow up with PCP recommended. The left upper arm severe pain started to get better the next day; Since then she has been feeling better with left shoulder pain (6/10) and more so with pressing on the area. Left shoulder limitation in ROM. She has not been able to do some home tests without pain. She feels that she is a little weaker because of that. Her left hand grasps remains good though her other range of motion of the elbows, wrists, fingers remain good. The right upper extremity is unaffected. She is not able to brush her hair and do left UE tasks a little better but not back to normal due to pain. No breathing problems, no chest wall pain. She states she has known rotator cuff problems in the past but was not symptomatic before the shot; she has known spine osteoarthritis and back pain. She follows with physician therapy for this regarding no loss of consciousness with incontinence of urine, she states that she had something similar when she had severe back pain. She has pulmonary artery hypertension. She is on: LETAIRIS 10 mg tab Take 1 tab by mouth one time daily.
noticed large hive under lt eye then lt cheek became swollen; several hives noted during evening; lt side of face swollen @ noc & for next 2 nocs only (not during day); no treatment required;
318 patients received dose from vials beyond 30-day use by date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date). On 19-Aug-2021, EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided.  No treatment medications were provided.  Date of refrigeration of vial was 7 May 2021.   This case was linked to MOD-2021-363245, MOD-2021-363032, MOD-2021-363032 (Patient Link).
Swelling to left upper arm & Itching. Antibiotics prescribed. Ice for swelling. Benadryl as needed for severe itching.
pt recvd vax; devel area of redness, warmth & soreness at inject site; the following day, area was 4.5cm & very hot, painful & red;
Patient came into pharmacy two days after immunization with redness on same arm as immunization. The redness was not at the injection site.
Left arm where shot was given swelled, hardened and was hot. Shot was given in the afternoon on Friday and arm swelled by Saturday AM to about 4" in diameter. Saturday PM was 6" in diameter and on Sunday PM, down to elbow and under arm. On Monday swelling shrinks.
numerous, discrete, pink to rose colored papule on all surfaces sparing palms and soles. no vesicles seen
had it twice, took the 2 in a series vac/suspected vaccination failure; had it twice; Left me with nerve damage; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and nerve damage. On an unknown date, the outcome of the vaccination failure, shingles and nerve damage were unknown.   The reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine. It was unknown if the reporter considered the nerve damage to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows:  The patient self-reported this case.                                        The age at vaccination was not reported. The patient had shingles twice and got once from the Shingle vaccine which was faulty some years ago from reporting date.  The patient took both Shingle vaccine in a series, 4 years ago from reporting date.  The patient was left with nerve damage. The patient reported that he/she would not wish this on his/her worst enemy. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure since the details regarding time to onset and laboratory test confirming shingles were unknown at the time of reporting.
Patient has not had an adverse reaction. Patient was given DTap and Engerix-B at the same time during her office visit today. Patient did not exhibit any signs of adverse reaction before leaving the clinic.
I had low grade fever, chills, body aches and joint pains which cause me to barely stand up. These symptoms lasted for about 24 hours. Since I'm pregnant I couldn't take  any Ibuprofen being pregnant(estimated date of delivery) 3/16/2021.
No Adverse reaction FLUZONE QUADRIVALENT dose of 0.5ml was administered (discovered on 12/22/2016).
I started getting random heart palpitations daily and there were at least 40 incidents per day; therefore, I went to the ER on 06/02/2021 and they ran an EKG and several blood tests. One of the blood tests just showed that I had a cardiac event. The EKG showed that I had a shorten PR interval. The ultimate decision was that I needed to have a follow up echo cardiogram and wear a heart monitor for a month.
little bit of a swollen arm; This is a spontaneous report from a Pfizer Sponsored program . A contactable consumer (patient herself) reported that a 67-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number, and expiration date not reported), via an unspecified route of administration on 18Feb2021, as first dose, single dose for COVID-19 immunisation. Medical history included ongoing allergy. Concomitant medication included fexofenadine hydrochloride (ALLEGRA) taken for allergy from an unspecified start date and ongoing. The patient experienced little bit of a swollen arm on an unspecified date. Patient stated that she received her first dose of the Pfizer COVID-19 vaccine on 18Feb2021 and experienced a little bit of a swollen arm but it was no big deal. Patient would like any information regarding the use of antihistamines specifically ALLEGRA with the Pfizer COVID-19 vaccine. She stated that she has allergies and this is a medication that she takes on a daily basis. The outcome of event was unknown.  No follow-up attempts are needed; information on lot/batch number cannot be obtained.
Information has been received from a registered nurse concerning a Caucasian female with allergies to CODEINE, METHANOL and PENICILLIN who on 21-FEB-2007 was vaccinated with a dose of RECOMBIVAX HB (654018/0904F).  Concomitant therapy included LIPITOR, fexofenadine hydrochloride, fluticasone propionate and PATANOL.  A nurse mentioned a patient completed the RECOMBIVAX HB series and the titer was found to be "0" from labs drawn on 31-Oct-2007 and results drawn in the beginning of Dec-2007.  The patient also had a "cold" on Dec-2007 and was "not feeling well".  The patient was found to have elevated liver enzymes from labs drawn on 15-Jan-2008 (AST- 80, ALT- 128).  The patient was taking atorvastatin calcium 20 mg prior to receiving RECOMBIVAX HB and because of the elevated liver enzymes, was told to cut the dose of atorvastatin calcium in half.  The patient had labs drawn on 12-Feb-2008 and liver enzymes were elevated again (AST - 92, ALT - 151).  The nurse also noted that the patient's cholesterol went up from 110 to 141, triglycerides went from 46 to 90, LDL went from 53 to 70, and HDL went from 40 to 50.  The patient received 1st dose of RECOMBIVAX HB on 21-Feb-2007, 2nd dose of RECOMBIVAX HB on 21-Mar-2007 and 3rd dose of RECOMBIVAX HB on 28-Aug-2007.  All doses were given as 1 ml, IM in the left deltoid.  Liver enzymes prior to starting RECOMBIVAX HB series was unknown.  It was not reported if the patient recovered.  Regards to medical attention, the patient called the nurse.  Follow up information and laboratory results received from the RN, indicated that the patient had a medical history of increased lipids.  There was no illness at the time of vaccination.  On 04-MAR-2008, the patient was considered recovered from the increased liver function tests, as AST and ALT had "dropped to near normal" (AST, 41 U/L; ALT 76 U/L).  In March of 2008, following the labs, the patient restarted (LIPITOR), but on 23-MAR-2008 it was discontinued, and QUESTRAN Light was initiated.  On 21-APR-2008, the AST had increased to 107 U/L, and ALT to 187 U/L, with all of the following lab results within normal rang; triglycerides, cholesterol, LDL cholesterol, VLDL cholesterol, HDL cholesterol.  The nurse indicated the physician had been advised to "hold on second hepatitis B series for present time."  Additional labs were planned for June.  Additional information is not expected.  Medical records provided upon request.
Right arm redness(softball size), swollen, itchy, warm to the touch, sore started on 9-5-09.  Pt used benadryl and calamine lotion starting on 9-6-09 - 9-9-09.  Pt saw family physician on 9-9-09 Rx for a topical cream given, told pt to discontinue putting calamine to the area, also told pt to switch soaps to dove and take cool showers call him in a week(per pt).
This spontaneous report as received from a health professional refers to a 4 year old patient. On 17-JUN-2014 the patient was vaccinated with a dose of (oka/merck) VARIVAX (lot # J013907, expiration date: 30-OCT-2015) dose and route not reported) which was stored improperly. There was no adverse effect reported. This is one of several reports from the same source. Additional information is not expected.
pt recv vax 2JAN96 & 8JAN96 pt exp flu-like sx, felt achy all over & lightheaded pt recovered;
Patient had normal injection site reaction on day vaccine was given, and then it started to move down her arm each day after, but resolved at previous site. When presented at pharmacy two days later inner arm near elbow was red, inflammed, and warm to the touch. Upon examination of injection site, and rest of upper arm, there was no inflammation, everything looked normal. Patient wasn't experiencing any itching either.
her husband contracted SARS-Cov-2 10 days after vaccination; her husband contracted SARS-Cov-2 10 days after vaccination; This is a spontaneous report from a contactable Physician (patient's wife). This physician reported similar events for two patients. This is the second of two reports. A male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in Jan2021 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported.  The patient (reporter's husband) contracted sars-cov-2 10 days after vaccination in Jan2021. The physician was looking for direction on receiving the second dose. Outcome of the event was unknown.   Information about Batch/Lot number has been requested.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation. However, full immunity is only expected 2 weeks after the second dose.,Linked Report(s) : US-PFIZER INC-2021025409 same reporter/drug/events, different patients
Since the 2nd vaccine my menstrual cycle has been messed up.; My first two periods/PMS resulted in excruciating cramping, comparable to labor contractions; Last months menstrual cycle was very short; This month I'm 2 weeks late.; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 35 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 30Aug2021 15:00 (Batch/Lot number: unknown) at the age of 35 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Systemic Lupus" (unspecified if ongoing), notes: never affected my menstrual cycle; "tubal litigation", start date: 2015 (unspecified if ongoing). There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown. Not able to get to card, Location of injection: Right arm, Vaccine Administration Time: 03:00 PM), administration date: 08Aug2021, when the patient was 35 years old. The following information was reported: MENSTRUAL DISORDER (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Since the 2nd vaccine my menstrual cycle has been messed up."; DYSMENORRHOEA (non-serious) with onset 14Sep2021, outcome "not recovered", described as "My first two periods/PMS resulted in excruciating cramping, comparable to labor contractions"; POLYMENORRHOEA (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Last months menstrual cycle was very short"; MENSTRUATION DELAYED (non-serious) with onset 14Sep2021, outcome "not recovered", described as "This month I'm 2 weeks late.". The events "since the 2nd vaccine my menstrual cycle has been messed up.", "my first two periods/pms resulted in excruciating cramping, comparable to labor contractions", "last months menstrual cycle was very short" and "this month i'm 2 weeks late." were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of menstrual disorder, dysmenorrhoea, polymenorrhoea, menstruation delayed.  Additional information: Since the 2nd vaccine my menstrual cycle has been messed up. My first two periods/PMS resulted in excruciating cramping, comparable to labor contractions. Last months menstrual cycle was very short. This month I'm 2 weeks late. I've taken a pregnancy test and it's negative. I had a tubal litigation in 2015 so I didn't think it was that but I wanted to make sure. I've never had any timing issues with my periods or irregular symptoms until now. I've discussed this with many female friends who experienced similar problems after the full vaccines but there is little research available on it. Patient did not receive other vaccine in four weeks. Patient was not receiving other medications in two weeks. Patient did not received treatment for AE. If covid prior vaccination: No. If covid tested post vaccination: No. Known allergies: No  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Rigors; Severe myalgias; Neck stiffness; Nausea; This is a spontaneous report from a contactable physician (patient) reported for herself. A 26-year-old non pregnant female patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection), dose 3 via an unspecified route of administration, administered in left arm on 29Sep2021 at 14:15 (at the age of 26-year-old) (Batch/Lot Number: PfizerFF8841) as dose 3 (booster), single for covid-19 immunisation and influenza vaccine (INFLUENZA), via an unspecified route of administration from 29Sep2021 (Batch/Lot number was not reported) to 29Sep2021, at unspecified dose for an unspecified indication. Medical history included ADD (attention deficit hyperactivity disorder), asthma and hypermobile ehlers danlos, all from an unknown date and unknown if ongoing. Patient previously took first dose and second dose of BNT162B2 on an unspecified date in 2021 for covid-19 immunisation. Concomitant medications included fexofenadine hydrochloride (ALLEGRA), acetaminophen and bupropion, where all the medications were taken for an unspecified indication, start and stop date were not reported. Patient had no known allergies. On 30Sep2021 at 03:30 the patient experienced rigors, severe myalgias, neck stiffness and nausea. Patient did not receive any other vaccines within 4 weeks to the COVID vaccine. The patient was not tested positive for covid 19 prior to vaccination and had not been tested post vaccination. Patient did not receive treatment post onset of the event. Outcome of all the events was not recovered.   Follow-up attempts are completed. No further information is expected.
Patient presented 3 days after vaccination with splotchy rash on arm that received vaccination- said it appeared about an hour after the immunization and had not changed much- she has felt fine and had no other symptoms.